aspirin
/ Generic mfg.
- LARVOL DELTA
Home
Next
Prev
1 to 25
Of
21580
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
July 17, 2025
Assessing transfusion need in patients with type A aortic dissection with multiplate aggregometry.
(PubMed, PLoS One)
- "Multiplate® aggregometry can be a useful tool for evaluating platelet dysfunction and assessing transfusion need in ATAAD patients, thereby aiding in the optimization of treatment strategies."
Journal • Observational data • Retrospective data
July 17, 2025
Prevention of unfavorable fibrin clots and thrombo-embolic manifestations in patients with cardiovascular disease.
(PubMed, Expert Rev Cardiovasc Ther)
- "Anticoagulants (heparins, vitamin K antagonists, and direct oral anticoagulants), aspirin, and statins favorably modify fibrin clot characteristics, which might contribute to their efficacy in various clinical settings. Encouraging results suggest that also novel treatments not yet approved in cardiovascular disease, including factor XI inhibitors and lipoprotein (a) reducing agents, might be beneficial, in part through improved fibrin clot phenotype, which gives hope for reducing the residual risk of thromboembolism in cardiovascular disease which persists despite the recommended management."
Journal • Review • Atrial Fibrillation • Cardiovascular • Congestive Heart Failure • Coronary Artery Disease • Heart Failure • Ischemic stroke • Myocardial Infarction • Peripheral Arterial Disease
July 17, 2025
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
(clinicaltrials.gov)
- P1/2 | N=400 | Recruiting | Sponsor: Thomas Jefferson University | Not yet recruiting ➔ Recruiting
Enrollment open • Gynecology
July 17, 2025
Utility of the US Preventive Services Task Force for Preeclampsia Risk Assessment and Aspirin Prophylaxis.
(PubMed, JAMA Netw Open)
- "In this prospective cohort study of 5684 singleton pregnancies, 89% of the population was assessed as having increased risk (moderate or high) of preeclampsia by USPSTF criteria. These findings suggest that moderate risk factors in the absence of high risk factors show no or low value for estimating the risk of developing preeclampsia, leading to nonspecific recommendations of AP in the moderate risk category."
Journal • Observational data • Cardiovascular • Diabetes • Genetic Disorders • Gynecology • Hypertension • Immunology • Metabolic Disorders • Nephrology • Obesity • Renal Disease
July 17, 2025
Assessment of Preclinical Antioxidative and Anti-Inflammatory Activities of Cornus macrophylla Wall. Bark.
(PubMed, Food Sci Nutr)
- "In the in vivo anti-inflammatory assay, the ethyl acetate (EA) fraction showed activity of 68.3%, 79.7%, and 83.7% at dosages of 50, 100, and 200 mg/kg B.W. (Body weight) of all the mice decreased when treated with LPS while it increased when treated with aspirin, crude extract, dichloromethane (DCM), and EA, respectively...The EA fraction markedly increases the level of catalase (CAT) by 46.26, 41.12, and 39.37 units/mg proteins at doses of 100, 200, and 300 mg/kg body weight, respectively. In vivo results validated the in vitro results of different fractions of C. macrophylla."
Journal • Preclinical • Inflammation • CAT
July 04, 2025
Identifying Pharmacologic Regulators Of Brown Adipose Tissue In Humans
(ENDO 2025)
- "Our results show that the incidence of starting nine medications (inhaled fluticasone, hydrochlorothiazide, vitamin D3, vitamin D2, exemestane, aspirin, amlodipine, letrozole, pantoprazole) was higher in the BAT positive group compared to the BAT negative group (OR >1, p<0.05), indicating that usage of these medications was associated with BAT activation. On the other hand, the incidence of starting escitalopram was significantly lower in the BAT positive group versus BAT negative group, as shown previously by others (2). In summary, our unique longitudinal analyses on medication usage have unraveled candidate medications that can potentially be repurposed to activate BAT in humans."
Late-breaking abstract • Diabetes • Genetic Disorders • Obesity • Oncology • Type 2 Diabetes Mellitus
July 04, 2025
A Case Of Bilateral Diabetic Muscle Infarction In The Arm And Leg: An Unusual Presentation
(ENDO 2025)
- "Cases of DMI have been described before, but upper extremity involvement is much rarer, as is involvement of multiple muscle groups, especially in bilateral extremities. It is possible that the IV infiltration caused microvascular injury that precipitated the DMI in her forearm, in addition to the typical involvement of the thigh. Trauma has not been previously reported as a precipitating factor for DMI but is plausible in this case with a unique presentation."
Clinical • Late-breaking abstract • Cardiovascular • Dermatology • Diabetes • Immunology • Infectious Disease • Metabolic Disorders • Myositis • Pain • Renal Disease • Reperfusion Injury • Retinal Disorders • Type 1 Diabetes Mellitus • Type 2 Diabetes Mellitus • Vasculitis
April 27, 2025
A Rare Case of Spontaneous Thyroid Hemorrhage Related to Anticoagulation Use and Multinodular Goiter
(ENDO 2025)
- "Apixaban was discontinued...Anticoagulation was stopped subsequently in another three months and aspirin was initiated...Cases of thyroid hemorrhage related to warfarin use have been reported in literature...Conservative management with serial imaging is appropriate, especially in the absence of airway symptoms. While fine needle aspiration may be considered, surgical evacuation is required for expanding hematomas or persistent respiratory symptoms."
Clinical • Atrial Fibrillation • Cardiovascular • Endocrine Disorders • Gastrointestinal Disorder • Hematological Disorders • Immunology • Inflammatory Arthritis • Ischemic stroke • Otorhinolaryngology • Pain • Rheumatoid Arthritis • Rheumatology
April 27, 2025
Double Trouble - A Case of Bilateral Adrenal Hemorrhage
(ENDO 2025)
- "Case:A 60 year old male with a history of hypertension, hyperlipidemia, transient ischemic attack on aspirin, and acid reflux came to the emergency room for worsening epigastric pain for weeks, unrelieved by antacid medications. He denied nausea, vomiting, diarrhea, or fevers, but recently took ibuprofen for the Flu...In our case, it was difficult to determine a cause and diagnose BAH due to non-specific symptoms, especially without the presence of AI. Early recognition is key as patients require monitoring for AI to reduce mortality."
Clinical • Cardiovascular • Dyslipidemia • Endocrine Disorders • Gastroesophageal Reflux Disease • Hematological Disorders • Hypertension • Infectious Disease • Nephrology • Pain • Renal Disease • Septic Shock • Thrombosis
April 27, 2025
TSH Secreting Adenoma vs. Thyroid Hormone Resistance
(ENDO 2025)
- "A total T4 was also obtained to rule out any condition in which there is decreased T4 binding to TBG, which would result in high free T4 with low total T4; both salicylates and certain NSAIDs can do this (the patient was taking aspirin and meloxicam). In conclusion, the more likely diagnosis therefore seems to be Resistance to Thyroid Hormone. Further diagnostic testing will be done to confirm that."
Cardiovascular • Chronic Obstructive Pulmonary Disease • Endocrine Disorders • Gastrointestinal Disorder • Immunology • Infectious Disease • Musculoskeletal Diseases • Musculoskeletal Pain • Orthopedics • Otorhinolaryngology • Pain • Respiratory Diseases • Thyroid Gland Carcinoma
April 27, 2025
Refractory Painful Hashimoto's Thyroiditis
(ENDO 2025)
- "Treatment options include l-thyroxine, NSAIDs, or aspirin; however, if symptoms persist, surgical intervention may be necessary.Clinical Case A 23-year-old female G1P0 with PTSD was referred to endocrinology at 14 weeks gestational age for subclinical hypothyroidism and mild neck pain...Initial treatment with prednisone 40 mg daily for one week provided temporary relief, while NSAIDs were ineffective...In this case, the lack of response to glucocorticoids, along with normal CRP and ESR levels, led to the diagnosis. Surgery may be an option if other treatments do not adequately manage symptoms."
CNS Disorders • Dermatology • Endocrine Disorders • Fatigue • Infectious Disease • Musculoskeletal Pain • Oncology • Pain • Post-traumatic Stress Disorder • Pruritus
July 17, 2025
Assessment of Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban, or Aspirin Plus REGN9933, or Aspirin Plus REGN7508 in Healthy Adult Participants
(clinicaltrials.gov)
- P1 | N=224 | Completed | Sponsor: Regeneron Pharmaceuticals | Active, not recruiting ➔ Completed
Trial completion
July 17, 2025
Salicylic Acid Engages Central Metabolic Regulators SnRK1 and TOR to Govern Immunity by Differential Phosphorylation of NPR1.
(PubMed, bioRxiv)
- "Under normal growth conditions, TARGET OF RAPAMYCIN (TOR) inhibits NPR1 through phosphorylation at Ser-55/59. This phosphorylation event activates NPR1 and facilitates its subsequent PTMs. Together, our results reveal an integral role of SA (the active metabolite of aspirin) in controlling central metabolic regulators SnRK1 and TOR to coordinate immune responses and growth through antagonistic modifications of NPR1."
Journal • Infectious Disease
July 17, 2025
Constructing a Preeclampsia Organoid Model to Elucidate the Mechanism of Aspirin.
(PubMed, Hypertension)
- "This study clarifies aspirin's multitarget mechanisms in alleviating preeclampsia, which include restoring the sFLT-1/PlGF balance, activating the PI3K-AKT-mTOR signaling pathway, optimizing mitochondrial function, and regulating CYP-mediated hormonal metabolism. These findings provide a mechanistic basis for aspirin's clinical effectiveness in preventing preeclampsia."
Journal • Cardiovascular • Gynecology • Hypertension • CYP19A1 • CYP1A1 • FLT1
July 17, 2025
Global Impact of Fixed-Dose Combination Therapies on Cardiovascular Mortality and Events, 2023-2050: A Modeling Study.
(PubMed, J Am Coll Cardiol)
- "SPC therapies could substantially accelerate progress on cardiovascular disease mortality by increasing use of preventive drugs, especially in settings where uptake is currently low."
Journal • Cardiovascular • Coronary Artery Disease • Heart Failure
July 17, 2025
Cost Savings of Switching to Aspirin for Thromboprophylaxis in Orthopaedic Trauma Patients: A Budget Impact Analysis.
(PubMed, J Am Acad Orthop Surg)
- "Our findings suggest that a widespread switch from enoxaparin thromboprophylaxis to aspirin would lead to more than $100 million in annual cost savings in the United States alone. Insurers stand to benefit most from this practice change. However, patients, especially those without insurance, would realize considerable savings from aspirin thromboprophylaxis."
HEOR • Journal • Cardiovascular • Musculoskeletal Diseases • Orthopedics • Respiratory Diseases • Venous Thromboembolism
July 16, 2025
Small intestinal bacteria accelerate aspirin-induced small intestinal injuries.
(PubMed, Exp Mol Pathol)
- "Enteric-coated, LDA-induced mucosal injuries in the small intestine are mainly caused by direct cytotoxicity of SA deacetylated by enterobacterial esterase in the small intestine."
Journal
July 15, 2025
Gut-Perm: Establishing and Validating a Meal-provoked Intestinal Permeability Test for Nutritional and Metabolic Health Clinical Research.
(clinicaltrials.gov)
- P=N/A | N=10 | Recruiting | Sponsor: Laval University
New trial
July 15, 2025
Formulation and Characterization of Multiparticulate System for Proton Pump Inhibitor using Combination Therapy for Peptic Ulcer.
(PubMed, Recent Adv Drug Deliv Formul)
- "The amla extract and esomeprazole magnesium enteric-coated granules with sustained release and negligible drug release in acidic pH were achieved. In the in vivo studies, the combination therapy demonstrated a significant positive effect in treating peptic ulcers in a rat ulcer model, as shown by assessments of various parameters such as ulcer index, total gastric juice acidity, hematological analysis, and histopathological evaluations."
Journal • Gastroenterology • Hematological Disorders • Peptic Ulcer
July 15, 2025
Acute digital ischemia in a child following a suspected arthropod bite: A case report.
(PubMed, Medicine (Baltimore))
- "This case emphasizes the importance of considering arthropod bite-induced vascular injury as a rare but significant differential diagnosis in pediatric digital ischemia. Early recognition and conservative management can lead to favorable outcomes and avoid invasive interventions."
Journal • Cardiovascular • Dermatology • Hematological Disorders • Pediatrics
July 15, 2025
Coagulation and Fibrinolysis Dysregulation in β-Thalassemia Major: Potential Impact of Splenectomy and Medications on Thrombotic Risk.
(PubMed, Clin Appl Thromb Hemost)
- "No significant differences in PS, D-dimer, PT, INR, aPTT, fibrinogen, PC, TF, tPA or ADAMTS13 were found between β-thalassemia major patients taking and not taking aspirin. However, a higher platelet count (+37.1%) and PAI-1 level (+58.9%), along with a lower vWF level (-25.6%), were observed between these two groups (all p < 0.05).ConclusionElevation in PAI-1 and platelet count in splenectomized β-thalassemia major could increase the risk of having a thrombotic event. Medications may have significant interactions with blood coagulation in β-thalassemia."
Journal • Beta-Thalassemia • Genetic Disorders • PROS1
July 15, 2025
Efficacy and safety of recombinant human granulocyte colony-stimulating factor in patients with unexplained recurrent pregnancy loss: a protocol for a multicenter, randomized, double-blind, controlled trial.
(PubMed, Trials)
- P=N/A | "This trial aims to provide high-quality evidence on the efficacy and safety of G-CSF in the treatment of uRPL, particularly in the Chinese population where existing data are limited. The findings may support evidence-based recommendations and inform treatment decisions in a population where therapeutic options remain limited and controversial."
Clinical • Journal • Diabetes • Gestational Diabetes • Gynecology • Metabolic Disorders
July 15, 2025
What dose of aspirin for preventing pre-eclampsia?
(PubMed, Drug Ther Bull)
- No abstract available
Journal • Gynecology
July 14, 2025
Evaluating the efficacy of antiplatelet therapy in spontaneous coronary artery dissection: a scoping review.
(PubMed, Cardiovasc Diagn Ther)
- "There is no clear consensus regarding the optimum antiplatelet medication regimen and treatment duration for SCAD despite current American Heart Association (AHA) consensus guidelines recommending 12-month regimen of dual antiplatelet therapy (DAPT) consisting of a P2Y12 inhibitor and aspirin for patients following myocardial infarction (MI)...These adverse outcomes, primarily driven by increased non-fatal MI and unplanned percutaneous coronary interventions (PCIs), highlight the challenges of DAPT in SCAD management. In patients treated with antiplatelet therapy, adverse events that include unstable angina, mortality, and repeat revascularization were greater in patients with more aggressive antiplatelet therapy consisting for safety and efficacy of DAPT compared with these treated with SAPT."
Journal • Review • Acute Coronary Syndrome • Cardiovascular • Coronary Artery Disease • Myocardial Infarction
July 14, 2025
Identifying Aspirin as a Contributing Factor to Persistent Gout: A Case Report.
(PubMed, Cureus)
- "Despite following strict lifestyle practices and medication compliance, pharmacological therapies were rendered ineffective until aspirin was identified as a contributing factor to his gout. Optimizing his medication regimen resolved his gout attacks, which stresses the concept that clinicians must be diligent with lesser-known side effects of medication to improve patient outcomes."
Journal • Cardiovascular • Gout • Inflammation • Inflammatory Arthritis • Metabolic Disorders • Rheumatology
1 to 25
Of
21580
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864